Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-Up

• Main Authors: Lukas Buendgens (Author), Eray Yagmur (Author), Axel Ginsberg (Author), Ralf Weiskirchen (Author), Theresa Wirtz (Author), Samira Abu Jhaisha (Author), Albrecht Eisert (Author), Tom Luedde (Author), Christian Trautwein (Author), Frank Tacke (Author), Alexander Koch (Author)
• Format: Book
• Published: Hindawi Limited, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Adrenomedullin (ADM) is a peptide with pleiotropic effects in systemic inflammation. Its more stable precursor protein midregional proadrenomedullin (MRproADM) can be measured more reliably compared to ADM. Our objective was to investigate the potential role of MRproADM as a diagnostic and prognosti...